Trials / Conditions / NMDAR Autoimmune Encephalitis
NMDAR Autoimmune Encephalitis
3 registered clinical trials studyying NMDAR Autoimmune Encephalitis — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Long-term Impact of NMDAR Encephalitis, Level 3 NCT07158229 | Hospices Civils de Lyon | — |
| Recruiting | Medium-term Effects of Treatments in Autoimmune Encephalitis NCT07133113 | Hospices Civils de Lyon | — |
| Recruiting | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in NCT05503264 | Hoffmann-La Roche | Phase 3 |